CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Beetroot juice +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05401409
NCT05401409N/ACompleted

Double-Blind, Randomised Placebo-Controlled Study to Determine the Effect of Beetroot Juice on Reducing Blood Pressure in Hypertensive Adults With Autosomal Dominant Polycystic Kidney Disease

Western Sydney Local Health District·interventional·Posted Jun 2, 2022·Updated Jun 8, 2025

In Brief

A clinical study evaluating Beetroot juice and Nitrate-depleted beetroot juice for Autosomal Dominant Polycystic Kidney and 2 related conditions. Completed, enrolled 60 participants across 2 sites.

Detailed Summary

People with autosomal dominant polycystic kidney disease (ADPKD) develop high blood pressure and kidney disease. Previous studies have shown that a commonly occurring chemical, nitric oxide (NO), is reduced in ADPKD, and may contribute, in part, to high blood pressure in this condition. Nitrate is found in high concentrations naturally in beetroots, and increases NO. The aim of this study is to determine if beetroot juice reduces blood pressure in hypertensive people with ADPKD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 2, 2022
Enrollment StartMay 5, 2022
Primary CompletionMar 24, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.1 years ago

Interventions

Beetroot juicedietary

70mls beetroot juice (400mg nitrate) given daily for 4 weeks

Nitrate-depleted beetroot juicedietary

70mls beetroot juice (nitrate-depleted) given daily for 4 weeks